Qube Research & Technologies Ltd - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 246 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q2 2023$2,065,656
+70.8%
250,991
+50.5%
0.01%
+60.0%
Q1 2023$1,209,170
+312.1%
166,782
+404.2%
0.01%
+150.0%
Q4 2022$293,393
-83.8%
33,077
-77.6%
0.00%
-81.8%
Q3 2022$1,811,000
+408.7%
147,929
+690.7%
0.01%
+266.7%
Q1 2022$356,000
-50.0%
18,708
-30.2%
0.00%
-40.0%
Q4 2021$712,000
-18.8%
26,811
+25.6%
0.01%
-54.5%
Q3 2021$877,000
+34.9%
21,341
+37.8%
0.01%
+10.0%
Q1 2021$650,000
+35.4%
15,486
-9.5%
0.01%
+42.9%
Q3 2020$480,000
-55.0%
17,108
-52.5%
0.01%
-78.8%
Q4 2019$1,066,00035,9870.03%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders